Hi flynnsav
The only reason for spikes in share price since listing has been Covid related, hence the reliance on TGA approval
for self-use RAT. Its been almost 2 years since listing and the have only signed 1 contract for non Covid related products,
that being for HIV products with Viatris/Mylan.
Even a recent shareholder recommendation from one its major shareholders, Ellerston Capital, speaks only
to the upside in shareholder value as a result of TGA approval for self-use RAT.
Hi flynnsavThe only reason for spikes in share price since...
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
